Currently Viewing:
ACOG Annual Clinical and Scientific Meeting
Making Sense of MACRA in the OB/GYN Practice
April 22, 2018
Making the New Postpartum Visit a Gateway to Long-Term Health
April 27, 2018
From Coverage to Culture, Researchers Discuss Barriers to Long-Acting Contraception
April 28, 2018
Rear Admiral Dr Wanda Barfield: How CDC's LOCATe Tool Assesses Risk-Appropriate Care
April 28, 2018
Dr Mary Norine Walsh on Being Your Own Advocate
April 28, 2018
Obstetricians Are Well-Positioned to Diagnose, Treat Postpartum Depression, Speakers Say
April 28, 2018
Results on Brexanolone IV for Postpartum Depression Shared at ACOG
April 28, 2018
Former Ambassador Nancy Brinker on Bringing the Breast Cancer Conversation to the Forefront
April 29, 2018
Dr Curtis Lowery on Technology's Place in the Future of Healthcare
April 29, 2018
USPSTF Session Brings Lively Comments on Link Between Ratings, Coverage
April 30, 2018
Dr John Schorge on Palliative Care Practices in Ovarian Cancer
April 30, 2018
Dr Jamie Bakkum-Gamez Discusses the Importance of Enhanced Recovery Pathways
April 30, 2018
Dr Haywood Brown on the Importance of Postpartum Follow-Up
May 15, 2018
Dr Mary Norine Walsh on the Rise of Maternal Mortality in the United States
May 16, 2018
Former Ambassador Nancy Brinker on the Future of the Susan G. Komen Foundation
May 17, 2018
Dr Curtis Lowery: How Technology Can Lower Costs for OB/GYN Patients
May 18, 2018
Dr Curtis Lowery: The ANGELS Program and How It Benefits Patients
May 29, 2018
Dr Mary Norine Walsh Discusses Risks for Pregnant Women With Hypertension
May 30, 2018
Rear Admiral Dr Wanda Barfield Provides an Overview of the Biggest Challenges Neonatologists Face
June 13, 2018
Dr Curtis Lowery on How His Practice Uses Technology to Benefit Patients
June 15, 2018
Dr Jamie Bakkum-Gamez Discusses the Importance of Genetic Testing After Ovarian Cancer Diagnosis
June 16, 2018
Dr John Schorge Discusses Disparities in Care of Endometrial Cancer
June 19, 2018
Dr Mary Norine Walsh on Who Is at High Risk for Peripartum Cardiomyopathy
June 21, 2018
Currently Reading
Dr Haywood Brown on the Alliance for Innovation in Maternal Health
June 23, 2018

Dr Haywood Brown on the Alliance for Innovation in Maternal Health

Haywood Brown, MD, immediate past president of the American College of Obstetricians and Gynecology, discusses the Alliance for Innovation in Maternal health (AIM) program which is designed to decrease the top-leading causes of maternal morbidity and mortality.


Haywood Brown, MD, immediate past president of the American College of Obstetricians and Gynecology, discusses the Alliance for Innovation in Maternal health (AIM) program which is designed to decrease the top-leading causes of maternal morbidity and mortality.

Transcript

What is the Alliance for Innovation in Maternal health (AIM) and what have the results of the program been thus far?

Well first of all this is targeted towards patient safety. We know, for instance, that some of the major complications of pregnancy are hemorrhage, thromboembolism, and hypertension. So, the alliance on innovation and [maternal health] are geared toward decreasing maternal morbidity and mortality from the top-leading causes for maternal death [that are] obstetric-related. 

But the other thing that we’ve tied into that is [the] safe reduction of cesarean deliveries. Keep in mind that cesarean delivery is more complicated than a vaginal delivery, it’s more risky for all the complications. The safety bundles– if they’re incorporated properly at every single hospital– that will decrease morbidity and mortality. 

So, the idea of every hospital, regardless of its size [and] regardless of its location, having a “hemorrhage bundle” is essential. For us to be able to educate women on the proper follow up when they’ve had preeclampsia, using the guidelines of being seen within 72 hours or certainly 7 days, is that safety bundle. Making sure that we all understand what the risks are with cesarean delivery, and why it’s so important to lower that cesarean delivery rate.

But the other thing that we’ve most recently done is put together a disparity bundle to be attached to all those bundles. Because, as I showed in my slide yesterday, the disparity issue is real, but it’s very complex. And we recognize also that there are biases in the system– for underserved women based on insurance– and it’s really not just racial disparity, it’s economic disparity. I was just sharing that with someone the other day– if you’re poor and white, you still have higher risks because of the biases in the system. 

We have to pay attention to those type of things, and we can’t blame all of the disparity on comorbidities. We have to blame some of it on the biases that we bring to the system and how you treat it, and how you receive in the work place, in the environment, in the clinic, in the office, in the hospital.   

 
Copyright AJMC 2006-2018 Clinical Care Targeted Communications Group, LLC. All Rights Reserved.
x
Welcome the the new and improved AJMC.com, the premier managed market network. Tell us about yourself so that we can serve you better.
Sign Up
×

Sign In

Not a member? Sign up now!